Published in Clin Sci (Lond) on August 05, 2010
Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol (2011) 2.14
Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation (2011) 1.68
Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo. JACC Cardiovasc Imaging (2012) 1.48
White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol (2013) 1.47
Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol (2012) 1.44
Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement (2012) 1.21
Coronary risk correlates with cerebral amyloid deposition. Neurobiol Aging (2011) 1.17
Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins. Am J Physiol Heart Circ Physiol (2011) 1.14
Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol (2014) 1.05
Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet. J Cereb Blood Flow Metab (2011) 0.96
Interactive effects of vascular risk burden and advanced age on cerebral blood flow. Front Aging Neurosci (2014) 0.95
The role of inflammatory processes in Alzheimer's disease. Inflammopharmacology (2012) 0.92
Brain microvasculature and hypoxia-related proteins in Alzheimer's disease. Int J Clin Exp Pathol (2011) 0.90
Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep (2014) 0.88
Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiol Dis (2014) 0.87
Netrin 1 regulates blood-brain barrier function and neuroinflammation. Brain (2015) 0.86
Baseline cardiovascular risk predicts subsequent changes in resting brain function. Stroke (2012) 0.85
Interleukin-1 mediates neuroinflammatory changes associated with diet-induced atherosclerosis. J Am Heart Assoc (2012) 0.85
The role of APOE in cerebrovascular dysfunction. Acta Neuropathol (2016) 0.84
A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice. Neural Plast (2016) 0.81
Enhanced Aβ(1-40) production in endothelial cells stimulated with fibrillar Aβ(1-42). PLoS One (2013) 0.81
Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans. Int J Alzheimers Dis (2012) 0.81
Relations between metabolic homeostasis, diet, and peripheral afferent neuron biology. Adv Nutr (2014) 0.80
Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum. Alzheimer Dis Assoc Disord (2015) 0.79
Cell-to-cell communication and vascular dementia. Microcirculation (2012) 0.77
A systems biology analysis of brain microvascular endothelial cell lipotoxicity. BMC Syst Biol (2014) 0.77
The occurrence of cerebrovascular atherosclerosis in Alzheimer's disease patients. Clin Interv Aging (2013) 0.76
Characterizing blood-brain barrier perturbations after exposure to human triglyceride-rich lipoprotein lipolysis products using MRI in a rat model. Magn Reson Med (2015) 0.76
Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease. J Neuroimmunol (2012) 0.76
Comprehensive gene expression profiling reveals synergistic functional networks in cerebral vessels after hypertension or hypercholesterolemia. PLoS One (2013) 0.76
Lipotoxic brain microvascular injury is mediated by activating transcription factor 3-dependent inflammatory and oxidative stress pathways. J Lipid Res (2016) 0.76
Apolipoprotein epsilon 4 genotype is associated with less improvement in cognitive function five years after cardiac surgery: a retrospective cohort study. Can J Anaesth (2015) 0.75
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (1988) 13.54
Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 12.23
The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron (2008) 10.19
Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med (2002) 7.99
Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis (1988) 6.01
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 5.00
ApoE promotes the proteolytic degradation of Abeta. Neuron (2008) 4.75
The role of lipids and lipoproteins in atherosclerosis. Science (1950) 4.52
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest (2003) 4.42
Blood lipids and human atherosclerosis. Circulation (1950) 4.41
Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38
Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res (2005) 4.24
Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res (2002) 4.09
Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab (2006) 3.71
Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res (2006) 3.64
Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol (2003) 3.56
Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science (1991) 3.42
apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest (2008) 3.36
Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab (2006) 3.35
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology (2004) 3.23
Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol (2006) 3.13
Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem (1981) 3.02
Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol (2006) 2.98
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol (2009) 2.85
Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62
The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci (2002) 2.53
Neurodegenerative diseases and oxidative stress. Biomed Pharmacother (2004) 2.44
Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology (2003) 2.44
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev (2006) 2.38
Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem (2009) 2.33
Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med (1999) 2.32
Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature (1997) 2.26
Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis. J Biol Chem (2006) 2.26
ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. J Cell Sci (2005) 2.07
Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem (1996) 2.06
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging (2006) 2.03
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest (2008) 2.01
Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. Ann Neurol (1999) 1.96
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol (2005) 1.91
The molecular basis of the prevention of Alzheimer's disease through healthy nutrition. Exp Gerontol (2006) 1.82
Human apolipoprotein E: the Alzheimer's disease connection. FASEB J (1996) 1.78
Dietary recommendations in the prevention and treatment of coronary heart disease: do we have the ideal diet yet? Am J Cardiol (2004) 1.74
Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J Biol Chem (1988) 1.72
Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lipid Res (2008) 1.71
Altered lipid metabolism in brain injury and disorders. Subcell Biochem (2008) 1.69
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int J Dev Neurosci (2006) 1.68
Direct visualization of lipid deposition and reverse lipid transport in a perfused artery : roles of VLDL and HDL. Circ Res (2000) 1.67
Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation (2008) 1.67
The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol Cell Neurosci (2007) 1.66
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. Am J Physiol Gastrointest Liver Physiol (2006) 1.66
Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase. Proc Natl Acad Sci U S A (2003) 1.65
Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care (2007) 1.62
The Mediterranean diet: science and practice. Public Health Nutr (2006) 1.61
Neurovascular unit dysfunction: a vascular component of Alzheimer disease? Neurology (2007) 1.59
Update on hypertension and Alzheimer's disease. Neurol Res (2006) 1.55
A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death. Mol Biol Cell (2005) 1.55
Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology (2007) 1.53
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care (2008) 1.52
How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell (2004) 1.51
Putting cholesterol in its place: apoE and reverse cholesterol transport. J Clin Invest (2006) 1.49
Lipoprotein lipase: physiology, biochemistry, and molecular biology. Front Biosci (2001) 1.48
Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells. Mol Cell Biochem (2007) 1.47
In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol Neurobiol (2005) 1.46
Postprandial lipemia and cardiovascular disease. Curr Atheroscler Rep (2003) 1.45
Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci (2004) 1.45
Alzheimer's disease: the lipid connection. J Neurochem (2007) 1.45
APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology (1999) 1.44
Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics (2005) 1.44
Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol (2009) 1.42
Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2 : macronutrients. J Nutr Health Aging (2006) 1.41
Resveratrol--a boon for treating Alzheimer's disease? Brain Res Rev (2006) 1.40
Effects of flow patterns on the localization and expression of VE-cadherin at vascular endothelial cell junctions: in vivo and in vitro investigations. J Vasc Res (2005) 1.37
Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol Cell Neurosci (2009) 1.35
The role of cerebrovascular disease in dementia. Neurologist (2003) 1.35
High-fat diet, muscular lipotoxicity and insulin resistance. Proc Nutr Soc (2007) 1.32
The metabolic syndrome and Alzheimer disease. Arch Neurol (2007) 1.31
Modulation of apolipoprotein E structure by domain interaction: differences in lipid-bound and lipid-free forms. J Biol Chem (2005) 1.29
24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J Biol Chem (2006) 1.28
Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res (2002) 1.27
Oxysterols, cholesterol homeostasis, and Alzheimer disease. J Neurochem (2007) 1.26
Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol (2005) 1.26
Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharm Des (2006) 1.26
The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides. Philos Trans R Soc Lond B Biol Sci (2005) 1.24
Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis. Am J Physiol Heart Circ Physiol (2007) 1.24
Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma. Neurobiol Dis (2006) 1.23
Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies. Atherosclerosis (2006) 1.21
Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol (2006) 1.21
Docosahexaenoic acid and the aging brain. J Nutr (2008) 1.20
Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am J Pathol (2001) 1.19
The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages. J Lipid Res (2006) 1.19
Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence. Acta Neurol Scand Suppl (2006) 1.19
Inhibition of angiogenesis by Abeta peptides. Angiogenesis (2004) 1.19
Effects of polymorphism on the lipid interaction of human apolipoprotein E. J Biol Chem (2003) 1.17
Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J Biol Chem (1983) 1.17
Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation. Neurol Res (2003) 1.16
Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. J Neurol Sci (2007) 1.16
Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. Biofactors (2009) 1.14
Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol (2010) 2.84
Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ Res (2007) 2.83
Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect (2006) 2.01
Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lipid Res (2008) 1.71
Postprandial lipemia and cardiovascular disease. Curr Atheroscler Rep (2003) 1.45
Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr (2011) 1.45
Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genomics (2002) 1.32
Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis. Am J Physiol Heart Circ Physiol (2007) 1.24
Chronic high fat feeding attenuates load-induced hypertrophy in mice. J Physiol (2009) 1.22
Fatty acids from very low-density lipoprotein lipolysis products induce lipid droplet accumulation in human monocytes. J Immunol (2010) 1.22
17 Beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2003) 1.20
Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis (2005) 1.12
Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development. J Lipid Res (2007) 1.08
Regulation of gene expression in RAW 264.7 macrophage cell line by interferon-gamma. Biochem Biophys Res Commun (2006) 1.07
Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids. J Immunol (2013) 1.07
Simultaneous forward and epi-CARS microscopy with a single detector by time-correlated single photon counting. Opt Express (2008) 1.03
Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men. Clin Appl Thromb Hemost (2002) 1.02
Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice. Am J Physiol Regul Integr Comp Physiol (2002) 1.00
The challenge of type 1 diabetes mellitus. ILAR J (2004) 0.95
Triglyceride-rich lipoprotein lipolysis increases aggregation of endothelial cell membrane microdomains and produces reactive oxygen species. Am J Physiol Heart Circ Physiol (2008) 0.93
Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon-gamma-mediated gene expression in human endothelial cells. J Biol Chem (2005) 0.93
Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate. Am J Physiol Heart Circ Physiol (2005) 0.92
Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. Vascul Pharmacol (2007) 0.91
Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci (2011) 0.91
Induction of ATF3 gene network by triglyceride-rich lipoprotein lipolysis products increases vascular apoptosis and inflammation. Arterioscler Thromb Vasc Biol (2013) 0.90
Synergistic effect of angiotensin II and nitric oxide synthase inhibitor in increasing aortic stiffness in mice. Am J Physiol Heart Circ Physiol (2005) 0.90
Postprandial monocyte activation in response to meals with high and low glycemic loads in overweight women. Am J Clin Nutr (2007) 0.89
Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation. J Immunol (2009) 0.89
Coronary artery revascularization in patients with diabetes mellitus. Circulation (2013) 0.89
Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Arterioscler Thromb Vasc Biol (2006) 0.89
Imaging apolipoprotein AI in vivo. NMR Biomed (2011) 0.88
Influence of folate on arterial permeability and stiffness in the absence or presence of hyperhomocysteinemia. Arterioscler Thromb Vasc Biol (2006) 0.88
A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol (2011) 0.87
VLDL lipolysis products increase VLDL fluidity and convert apolipoprotein E4 into a more expanded conformation. J Lipid Res (2009) 0.85
17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice. J Cardiovasc Transl Res (2009) 0.85
Comparative gene responses to collected ambient particles in vitro: endothelial responses. Physiol Genomics (2011) 0.84
Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury. Am J Physiol Heart Circ Physiol (2002) 0.84
Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wall. Arterioscler Thromb Vasc Biol (2002) 0.84
Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo. J Cell Mol Med (2009) 0.84
Hyperhomocysteinemia evoked by folate depletion: effects on coronary and carotid arterial function. Arterioscler Thromb Vasc Biol (2002) 0.84
Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase. Curr Atheroscler Rep (2009) 0.83
C-terminal interactions of apolipoprotein E4 respond to the postprandial state. J Lipid Res (2006) 0.83
Modulation of vascular inflammation by PPARs. Drug News Perspect (2003) 0.83
Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB. Am J Physiol Heart Circ Physiol (2013) 0.82
Apolipoprotein E mediates the retention of high-density lipoproteins by mouse carotid arteries and cultured arterial smooth muscle cell extracellular matrices. Circ Res (2002) 0.81
Time- and dose-dependent differential upregulation of three genes by 17 beta-estradiol in endothelial cells. J Appl Physiol (1985) (2002) 0.80
Label-free imaging and analysis of the effects of lipolysis products on primary hepatocytes. J Biophotonics (2010) 0.80
Postprandial apoE isoform and conformational changes associated with VLDL lipolysis products modulate monocyte inflammation. PLoS One (2012) 0.79
Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart disease. Gut Microbes (2011) 0.79
Apolipoprotein E3- and nitric oxide-dependent modulation of endothelial cell inflammatory responses. Arterioscler Thromb Vasc Biol (2006) 0.79
Postprandial elevation of tissue factor antigen in the blood of healthy adults. Thromb Haemost (2005) 0.78
Interaction between mild hypercholesterolemia, HDL-cholesterol levels, and angiotensin II in intimal hyperplasia in mice. J Lipid Res (2005) 0.78
Urokinase-type plasminogen activator deficiency (uPA-KO) prevented carotid artery ligation-induced vascular remodeling in mice. Transl Res (2007) 0.78
Lipid-cell interactions in human monocytes investigated by doubly-resonant coherent anti-Stokes Raman scattering microscopy. J Biomed Opt (2011) 0.77
A systems biology analysis of brain microvascular endothelial cell lipotoxicity. BMC Syst Biol (2014) 0.77
Testosterone-derived estradiol production by male endothelium is robust and dependent on p450 aromatase via estrogen receptor alpha. Springerplus (2013) 0.77
Maternal and neonatal exposure to environmental tobacco smoke targets pro-inflammatory genes in neonatal arteries. J Cardiovasc Transl Res (2010) 0.77
Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability. Am J Physiol Regul Integr Comp Physiol (2006) 0.77
Hyperhomocysteinemia increases arterial permeability and stiffness in mice. Am J Physiol Regul Integr Comp Physiol (2006) 0.76
Role of triglyceride-rich lipoproteins in renal injury. Contrib Nephrol (2011) 0.76
Differential regulation of gene expression by ovariectomy in mouse aorta. Physiol Genomics (2003) 0.75
Links between food and vascular disease. Am J Clin Nutr (2002) 0.75